Byotrol : Annual Report and Accounts

Byotrol Plc

Annual Report

and

Financial Statements

for the year ended 31 March 2022

Registered number: 05352525

COMPANY INFORMATION

Board of Directors

CONTENTS

Byotrol plc

• About Byotrol
• Board of Directors
• Chairman's statement
• CEO's report

Strategic Report

• Key Performance Indicators
• Principal risks and uncertainties
• Financial review
• s.172 statement

Corporate governance review

Report of the Directors and Financial Statements

• Directors' report
• Independent auditor's report
• Group statement of comprehensive income
• Group statement of financial position
• Group statement of cash flow
• Group statement of changes in equity
• Notes to the Group financial statements
• Company statement of financial position
• Company statement of changes in equity
• Notes to the Company financial statements

About Byotrol

Byotrol is dedicated to improving lives around the world by developing and commercialising market-leading infection control and prevention products. We specialise in high performance, sustainable and regulatory-approved antimicrobial technologies and products, especially those which challenge traditional sanitisation and cleaning methods.

Our technologies are utilised across professional and consumer markets, in products for both surfaces and skin, in environments where good hygiene is of the greatest importance. Byotrol's laboratories are based at Thornton Science Park, a University of Chester campus in the North-West of England, where the Group also hosts its commercial operations.

Byotrol's territories of sale have grown significantly in recent years and our products are now sold and used throughout Europe, North America, South Africa and Asia. Byotrol is active in the following market sectors:

• Professional
• • Human Health
  • Animal Health
  • Facilities Management
  • Food & Beverage
• Consumer
• • Household
  • Skin Care
  • Pet Care

Byotrol believes in scientific excellence, superior hygiene, the responsible use of biocides and, above all, easier, cleaner, safer lives for everyone.

Byotrol's corporate history

1990's Byotrol's first antimicrobial technology was invented and patented 2005 The Company floated on the London AIM market

2007 Byotrol Consumer Products set up in joint venture with Byotrol plc and WhatIf Ventures 2010 First consumer hand sanitiser launched in Boots

2011 Consumer household surface care range launched in Tesco

2013 Byotrol plc acquired remaining share of Byotrol Consumer Products from WhatIf Ventures 2014 Actizone patent granted in the UK

2016 PAS 2424 long-lasting antimicrobial test method developed in conjunction with the BSI

2017 Byotrol launches new Invirtu alcohol free hand sanitiser: the US Environmental Protection Agency grant approval of Byotrol's proprietary 24-hourgerm-kill surface sanitiser

2018 Byotrol acquires Medimark Scientific Limited, a leading provider of biocide-based infection control products for the animal and human healthcare markets

2019 Byotrol sells patents and underlying IP to Solvay SA, whilst retaining rights to sell Actizone in finished product form; completes licences with two key suppliers into UK NHS - with SC Johnson Professional on alcohol free hand sanitisers; and with Tristel on (non-sporicidal)anti-microbial surface care chemistries

2020 Byotrol accelerates earnout payments relating to Medimark Scientific, allowing final integration of the two companies

2021 Byotrol achieves significant profitability; licences technology to transfer US operations to third party

2022 Byotrol centralises its commercial operations into Thornton Science Park, alongside the existing laboratory facilities